Assessment of prognostic factors for locally advanced breast cancer
- PMID: 23360018
Assessment of prognostic factors for locally advanced breast cancer
Abstract
In spite of apparent improvement in outcome in locally advanced breast cancer, the prognosis remains dismal in many patients. The aim of this study was to define prognostic subgroups within this heterogeneous entity. The prospective follow-up study was carried out for a period of three and half years involving patients attending the radiotherapy department of Burdwan Medical College and Hospital. Forty-five patients with clinical stages IIIA and IIIB breast cancer were treated with neoadjuvant chemotherapy followed by mastectomy, radiotherapy and completion of chemotherapy with an objective to assess the 2 years disease free and overall survival and to find out the correlates of prognosis. On follow-up disease-free survival and overall survival at 2 years were noted to be 60% and 80% respectively. Patients with age more than 45 years, earlier stage, less than 4 positive axillary nodes, tumour size less than 8 cm, oestrogen receptor positive and Her-2-neu negative status and lesser number of chemotherapy cycles required before surgery had better outcome though not statistically significant. Thus it can be concluded that the above mentioned prognostic variables are strong predictors of treatment outcome in locally advanced breast cancer though further studies with larger sample size are required to establish their statistical significance.
Similar articles
-
[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029696 Chinese.
-
[Clinical characteristics and prognosis of breast cancer patients with vascular invasion].Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):137-40. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17645853 Chinese.
-
[Clinical features and prognosis analysis of different breast cancer molecular subtypes].Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):42-6. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575463 Chinese.
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
Neoadjuvant chemotherapy in breast cancers.Womens Health (Lond). 2016 Sep;12(5):480-491. doi: 10.1177/1745505716677139. Womens Health (Lond). 2016. PMID: 27885165 Free PMC article. Review.
Cited by
-
Locally Advanced Breast Cancer (LABC): Real-World Outcome of Patients From Cancer Institute, Chennai.JCO Glob Oncol. 2021 May;7:767-781. doi: 10.1200/GO.21.00001. JCO Glob Oncol. 2021. PMID: 34043414 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous